Announcing C&M Health Law, Crowell & Moring's New Health Care Blog
Client Alert | 1 min read | 08.25.14
Crowell & Moring's Health Care Group is pleased to announce its new blog, C&M Health Law (www.cmhealthlaw.com).
Our goal is to provide real-time analysis and commentary on the latest developments in health care law and policy. We intend to provide value to readers by being insightful, analytical, and instructive regarding an increasingly complex and heavily regulated health care industry.
The blog's attorney authors are part of a diverse and growing practice from coast to coast. We have deep experience in the Affordable Care Act, health care antitrust, managed care, fraud and abuse (including Stark, anti-kickback and False Claims Act matters), Medicare Advantage and Prescription Drug Plans, Medicaid, the FEHBP, privacy and litigation throughout the field.
Our team serves a broad range of clients, including all of the top ten health insurers and many of the nation's leading health care providers and academic institutions, suppliers, and manufacturers, trade and professional associations, and emerging businesses. We have experience representing clients in all forms of civil and criminal disputes, including government enforcement actions, as well as meeting unique client needs across transactional, counseling, and compliance practices.
We invite you to follow the blog at www.cmhealthlaw.com and learn more about its authors.
You can also get updates via RSS feed or via email subscription by entering your email address in the field above "Topics" on the left-hand side of the blog.
Please contact the blog's editors, Art Lerner and Xavier Baker, with any questions.
Insights
Client Alert | 6 min read | 04.29.26
CMS Seeks to Expand Interoperability Requirements to Drug Pre-Authorization (FAQ)
On April 10, 2026, the Centers for Medicare and Medicaid Services (CMS) issued a proposed rule (2026 CMS Interoperability Standards and Prior Authorization for Drugs, or CMS-0062-P) outlining the agency’s plans to impose new interoperability requirements on payors participating in certain Medicare and Medicaid programs. As described by the agency in a recent press release, the proposed rule “builds on” prior rulemaking by clarifying and enhancing interoperability requirements for payors’ prior authorization processes, specifically those associated with coverage requests for pharmaceutical therapies.
Client Alert | 8 min read | 04.27.26
Client Alert | 5 min read | 04.27.26
Drift Protocol Exploit: Why “Social Trust” Is the Newest Cybersecurity Gap
Client Alert | 4 min read | 04.27.26
Gaming Addiction Litigation: Turner v. Epic Games & Roblox and What It Means for the Industry
